Posted in | Medical Robotics

Stereotaxis to Promote Niobe Magnetic Navigation System for Cardiac Ablations in Japan

Stereotaxis, Inc. today announced that it will present at the 29th Annual Meeting of the Japanese Heart Rhythm Society in Tokyo beginning July 23, 2014. The three-day event is the first large-scale opportunity for the Company's in-country distributors, Medix Japan, Inc. and Hokushin Medical Co. Ltd., to promote the clinical value of the Stereotaxis Niobe® Magnetic Navigation System for cardiac ablations to the Japan electrophysiology (EP) market.

Stereotaxis entered into an agreement with the two medical device distributors in February 2014 to market, sell and distribute the Niobe system and disposable devices to Japanese customers.

Medix Japan and Hokushin Medical have been in active dialogue with EP physicians on behalf of Stereotaxis. In conjunction with the commercialization efforts, the companies have been meeting with prestigious medical centers on the potential for research collaboration and preparing the necessary filings for regulatory approval of Stereotaxis' Vdrive™ Robotic Navigation System and Odyssey™ Information Management Solution product lines.

"We are very pleased with the level of commitment this team has demonstrated in bringing awareness of our technology to a high priority market, and we look forward to engaging with the Japanese EP community at Japan HRS this week," says William C. Mills, Stereotaxis Chief Executive Officer.

In addition to exhibiting at the event, the Company will be featured during a one-hour panel discussion on July 25, "Current Status and Future of Robotic Catheter Mapping and Ablation," presented by Dr. Hiroshi Nakagawa (University of Oklahoma Health Sciences Center) and moderated by Dr. Kenzo Hirao (Tokyo Medical and Dental University).

About Stereotaxis

Stereotaxis is a healthcare technology and innovation leader in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease, as well as information management solutions for the interventional lab. Over 100 issued patents support the Stereotaxis platform, which helps physicians around the world provide unsurpassed patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Stereotaxis' core Epoch™ Solution includes the Niobe® ES Remote Magnetic Navigation system, the Odyssey® portfolio of lab optimization, networking and patient information management systems and the Vdrive™ Robotic Navigation system and consumables.

The core components of Stereotaxis systems have received regulatory clearance in the U.S., European Union, Canada, China, Japan and elsewhere. The V-Sono™ ICE catheter manipulator has received U.S. clearance, and the V-Loop™ variable loop catheter manipulator and V-CAS™ catheter advancement system have been submitted for review by the U.S. Food and Drug Administration.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback